Senseonics Q4 revenue $14.3M (+72% YoY); guides FY26 revenue $58-62M

Senseonics Holdings, Inc.

Q4 2025 revenue $14.3M (+72% YoY); US revenue $12.1M vs $6.2M in Q4 2024.
Full year 2025 revenue $35.3M (+57% YoY); net loss $69.1M ($1.66 loss per share).
Received CE Mark for Eversense 365 in EU; FDA IDE approved for Gemini sensor pivotal trial.
2026 revenue guidance $58-62M (65-76% growth); gross margin expected ~50%.
Transitioned Eversense commercialization in-house; launched twiist AID system integration.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.